- Home
- CAH vs ZTS Comparison
CAH vs ZTS Comparison
Compare CAH & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAH | ZTS |
|---|---|---|
| Founded | 1979 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4B | 53.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | CAH | ZTS |
|---|---|---|
| Price | $201.10 | $127.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $204.75 | $174.60 |
| AVG Volume (30 Days) | 1.8M | ★ 5.8M |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | 1.02% | ★ 1.67% |
| EPS Growth | ★ 27.25 | 11.64 |
| EPS | ★ 6.63 | 5.94 |
| Revenue | ★ $234,310,000,000.00 | $9,397,000,000.00 |
| Revenue This Year | $16.60 | $3.04 |
| Revenue Next Year | $8.26 | $4.98 |
| P/E Ratio | $30.35 | ★ $21.42 |
| Revenue Growth | ★ 4.39 | 2.68 |
| 52 Week Low | $119.25 | $115.25 |
| 52 Week High | $214.93 | $177.40 |
Technical Indicators
Market Signals| Indicator | CAH | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 56.19 |
| Support Level | $201.02 | $124.55 |
| Resistance Level | $211.77 | $131.13 |
| Average True Range (ATR) | 3.43 | 2.55 |
| MACD | -0.71 | 0.52 |
| Stochastic Oscillator | 6.28 | 63.14 |
Price Performance
Historical ComparisonAbout CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.